Literature DB >> 16946133

Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring.

Tomoya Yamashita1, Stefan Freigang, Claudia Eberle, Jennifer Pattison, Sachin Gupta, Claudio Napoli, Wulf Palinski.   

Abstract

Maternal hypercholesterolemia during pregnancy increases offspring susceptibility to atherosclerosis by an oxidation-dependent mechanism. The present studies investigated whether maternal immunization with oxidized LDL (OxLDL) before pregnancy protects the fetus from atherogenic in utero programming by maternal hypercholesterolemia. Maternal immunization of NZW rabbits and LDL receptor-deficient mice indeed reduced atherosclerosis in adult offspring by up to 56%, but the protective effect could not be attributed to a reduction of fetal exposure to hypercholesterolemia alone, and even nonspecific immune stimulation with adjuvant only provided some protection. Unexpectedly, offspring of immunized mothers developed increased IgM antibodies to selective OxLDL epitopes and increased IgM-LDL immune complexes, compared with offspring of nonimmunized controls. Even naïve offspring of OxLDL-immunized mothers never exposed to postnatal hypercholesterolemia responded to a one-time OxLDL and KLH challenge with greater OxLDL-specific IgM responses, increased OxLDL-specific IgM-secreting B cells, and more IgM-LDL immune complexes. In contrast, maternal immunization with KLH, a T cell-dependent nonmammalian antigen, did not influence postnatal immune responses. Effects of maternal OxLDL-immunization on offspring B cells and selective antibodies were independent of transplacental passage of maternal immunoglobulins. Results show that maternal immunization with antigens prevalent in atherosclerotic lesions reduces atherogenesis in their offspring by mechanisms that include, but are not limited to, reduced fetal exposure to maternal hypercholesterolemia and lipid peroxidation. More importantly, they demonstrate in principle that maternal adaptive immunity to selective antigens influences postnatal B cell and antibody responses in offspring, and that modulation of in utero immune programming may influence immune-modulated diseases later in life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16946133     DOI: 10.1161/01.RES.0000244003.08127.cc

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  25 in total

Review 1.  Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases.

Authors:  P Roux-Lombard; S Pagano; F Montecucco; N Satta; N Vuilleumier
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

2.  Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.

Authors:  Gabriel Virella; Rickey E Carter; Antonio Saad; Edward G Crosswell; B Andrew Game; Maria F Lopes-Virella
Journal:  Clin Immunol       Date:  2008-06       Impact factor: 3.969

Review 3.  Atherogenesis and the humoral immune response to modified lipoproteins.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Atherosclerosis       Date:  2008-04-12       Impact factor: 5.162

4.  Maternally transferred anti-factor VIII IgG reduce the anti-factor VIII humoral immune response in factor VIII-deficient mice.

Authors:  Yann Meslier; Sébastien André; Maud Teyssandier; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

Review 5.  Effect of maternal cardiovascular conditions and risk factors on offspring cardiovascular disease.

Authors:  Wulf Palinski
Journal:  Circulation       Date:  2014-05-20       Impact factor: 29.690

Review 6.  Developmental mechanisms involved in the primary prevention of atherosclerosis and cardiovascular disease.

Authors:  Claudio Napoli
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

7.  Effect of gestational hypercholesterolemia and maternal immunization on offspring plasma eicosanoids.

Authors:  Oswald Quehenberger; Tomoya Yamashita; Aaron M Armando; Edward A Dennis; Wulf Palinski
Journal:  Am J Obstet Gynecol       Date:  2011-03-26       Impact factor: 8.661

8.  Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor Fc gamma RIIB expression on B cells.

Authors:  Jefferson R Victor; Bruno P Muniz; Ana E Fusaro; Cyro A de Brito; Eliana F Taniguchi; Alberto J S Duarte; Maria N Sato
Journal:  BMC Immunol       Date:  2010-03-11       Impact factor: 3.615

Review 9.  Clinical significance of the humoral immune response to modified LDL.

Authors:  Maria F Lopes-Virella; Gabriel Virella
Journal:  Clin Immunol       Date:  2009-05-08       Impact factor: 3.969

Review 10.  Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease.

Authors:  Wulf Palinski; Eric Nicolaides; Antonio Liguori; Claudio Napoli
Journal:  J Cardiovasc Transl Res       Date:  2009-05-29       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.